$NVAX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NOVAVAX INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in NOVAVAX INC. Get notifications about new insider transactions in NOVAVAX INC for free.

Page:   1 2 3 4 5 ... 8 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 29 2021NVAXNOVAVAX INCMCMANUS MICHAEL A JRDirectorOption ExerciseM0.006,90000
Jun 29 2021NVAXNOVAVAX INCMCMANUS MICHAEL A JRDirectorBuyM0.006,900012,8516 K to 12.9 K (+115.95 %)
Jun 22 2021NVAXNOVAVAX INCMOTT DAVID MDirectorOption ExerciseA0.007000700
Jun 22 2021NVAXNOVAVAX INCMOTT DAVID MDirectorOption ExerciseA179.891,300233,8571,300
Jun 22 2021NVAXNOVAVAX INCMCGLYNN MARGARET GDirectorOption ExerciseA0.007000700
Jun 22 2021NVAXNOVAVAX INCMCGLYNN MARGARET GDirectorOption ExerciseA179.891,300233,8571,300
Jun 22 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorOption ExerciseA0.001,40001,400
Jun 22 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorOption ExerciseA179.892,600467,7142,600
Jun 22 2021NVAXNOVAVAX INCEVANS GARY CDirectorOption ExerciseM0.003,45000
Jun 22 2021NVAXNOVAVAX INCEVANS GARY CDirectorBuyM0.003,450019,54916.1 K to 19.5 K (+21.43 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...Option ExerciseM5.953842,28511,117
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...Option ExerciseM5.952,08412,40060,417
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...Option ExerciseM46.0052123,96610,423
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...Option ExerciseM27.6041711,5093,341
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS176.609015,894287377 to 287 (-23.87 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS176.6510017,665377477 to 377 (-20.96 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...Payment of ExerciseF171.7418030,913477657 to 477 (-27.40 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellD171.74142,404657671 to 657 (-2.09 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...BuyM5.953842,285671287 to 671 (+133.80 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS194.086813,198287355 to 287 (-19.15 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS192.8124647,431355601 to 355 (-40.93 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS191.5341278,9096011 K to 601 (-40.67 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS190.6219236,5991,0131.2 K to 1 K (-15.93 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS189.4636468,9621,2051.6 K to 1.2 K (-23.20 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS188.5131859,9451,5691.9 K to 1.6 K (-16.85 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS187.3618634,8481,8872.1 K to 1.9 K (-8.97 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS186.0510519,5362,0732.2 K to 2.1 K (-4.82 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS184.2525246,4302,1782.4 K to 2.2 K (-10.37 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS183.4313825,3132,4302.6 K to 2.4 K (-5.37 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS182.4516029,1922,5682.7 K to 2.6 K (-5.87 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS181.178515,3992,7282.8 K to 2.7 K (-3.02 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS180.377012,6262,8132.9 K to 2.8 K (-2.43 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS171.89284,8132,8832.9 K to 2.9 K (-0.96 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS171.0920835,5862,9113.1 K to 2.9 K (-6.67 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS169.709315,7823,1193.2 K to 3.1 K (-2.90 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS168.34132,1883,2123.2 K to 3.2 K (-0.40 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS164.71121,9773,2253.2 K to 3.2 K (-0.37 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...SellS163.037211,7383,2373.3 K to 3.2 K (-2.18 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...BuyM5.952,08412,4003,3091.2 K to 3.3 K (+170.12 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...BuyM46.0052123,9661,225704 to 1.2 K (+74.01 %)
May 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, CCO, CBO & Int ...BuyM27.6041711,509704287 to 704 (+145.30 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.954,81928,67351,643
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.953,12418,58865,628
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM46.001,10150,64615,221
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.954,81928,67351,643
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.6086823,9575,737
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM5.953,12418,58865,628
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.0061916,7131,242
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM46.001,10150,64615,221
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS224.50494110,9052,8113.3 K to 2.8 K (-14.95 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.6086823,9575,737
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS221.6735678,9153,3053.7 K to 3.3 K (-9.72 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DOption ExerciseM27.0061916,7131,242
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS220.5743796,3903,6614.1 K to 3.7 K (-10.66 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS224.50494110,9052,8113.3 K to 2.8 K (-14.95 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS219.178117,7534,0984.2 K to 4.1 K (-1.94 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS221.6735678,9153,3053.7 K to 3.3 K (-9.72 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS218.4815333,4284,1794.3 K to 4.2 K (-3.53 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS220.5743796,3903,6614.1 K to 3.7 K (-10.66 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS217.2228461,6914,3324.6 K to 4.3 K (-6.15 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS219.178117,7534,0984.2 K to 4.1 K (-1.94 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS216.1141790,1174,6165 K to 4.6 K (-8.29 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS218.4815333,4284,1794.3 K to 4.2 K (-3.53 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS215.0113428,8125,0335.2 K to 5 K (-2.59 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS217.2228461,6914,3324.6 K to 4.3 K (-6.15 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS213.796113,0415,1675.2 K to 5.2 K (-1.17 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS216.1141790,1174,6165 K to 4.6 K (-8.29 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DPayment of ExerciseF202.092,260456,7235,2287.5 K to 5.2 K (-30.18 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS215.0113428,8125,0335.2 K to 5 K (-2.59 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellD202.0914228,6977,4887.6 K to 7.5 K (-1.86 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS213.796113,0415,1675.2 K to 5.2 K (-1.17 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM202.094,819973,8727,6302.8 K to 7.6 K (+171.43 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DPayment of ExerciseF202.092,260456,7235,2287.5 K to 5.2 K (-30.18 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS206.8212726,2662,8112.9 K to 2.8 K (-4.32 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellD202.0914228,6977,4887.6 K to 7.5 K (-1.86 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS205.698317,0732,9383 K to 2.9 K (-2.75 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM202.094,819973,8727,6302.8 K to 7.6 K (+171.43 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS204.7115231,1163,0213.2 K to 3 K (-4.79 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS206.8212726,2662,8112.9 K to 2.8 K (-4.32 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS204.0139179,7673,1733.6 K to 3.2 K (-10.97 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS205.698317,0732,9383 K to 2.9 K (-2.75 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS202.8541283,5743,5644 K to 3.6 K (-10.36 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS204.7115231,1163,0213.2 K to 3 K (-4.79 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS201.93833168,2083,9764.8 K to 4 K (-17.32 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS204.0139179,7673,1733.6 K to 3.2 K (-10.97 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS200.77605121,4644,8095.4 K to 4.8 K (-11.17 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS202.8541283,5743,5644 K to 3.6 K (-10.36 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS199.86959191,6705,4146.4 K to 5.4 K (-15.05 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS201.93833168,2083,9764.8 K to 4 K (-17.32 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS198.70717142,4656,3737.1 K to 6.4 K (-10.11 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS200.77605121,4644,8095.4 K to 4.8 K (-11.17 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS197.70873172,5947,0908 K to 7.1 K (-10.96 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS199.86959191,6705,4146.4 K to 5.4 K (-15.05 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS196.77560110,1907,9638.5 K to 8 K (-6.57 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS198.70717142,4656,3737.1 K to 6.4 K (-10.11 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM5.953,12418,5888,5235.4 K to 8.5 K (+57.86 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS197.70873172,5947,0908 K to 7.1 K (-10.96 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM46.001,10150,6465,3994.3 K to 5.4 K (+25.62 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DSellS196.77560110,1907,9638.5 K to 8 K (-6.57 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM27.6086823,9574,2983.4 K to 4.3 K (+25.31 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM5.953,12418,5888,5235.4 K to 8.5 K (+57.86 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM27.0061916,7133,4302.8 K to 3.4 K (+22.02 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM46.001,10150,6465,3994.3 K to 5.4 K (+25.62 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM27.6086823,9574,2983.4 K to 4.3 K (+25.31 %)
Apr 19 2021NVAXNOVAVAX INCGlenn Gregory MPresident, R&DBuyM27.0061916,7133,4302.8 K to 3.4 K (+22.02 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...Option ExerciseM5.953832,27911,501
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...Option ExerciseM5.952,08312,39462,501
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...Option ExerciseM46.0052123,96610,944
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...Option ExerciseM27.6041711,5093,758
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...SellS178.0319134,004287478 to 287 (-39.96 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...Payment of ExerciseF177.2917931,735478657 to 478 (-27.25 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...SellD177.29132,305657670 to 657 (-1.94 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...BuyM177.2938367,902670287 to 670 (+133.45 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...SellS190.103,021574,2922873.3 K to 287 (-91.32 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...BuyM5.952,08312,3943,3081.2 K to 3.3 K (+170.04 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...BuyM46.0052123,9661,225704 to 1.2 K (+74.01 %)
Apr 07 2021NVAXNOVAVAX INCTrizzino JohnEVP, Chief Commerci ...BuyM27.6041711,509704287 to 704 (+145.30 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...Option ExerciseM5.952,06212,26961,876
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...Option ExerciseM46.0041619,1368,759
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...Option ExerciseM27.6041611,4823,760
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS196.12479,218275322 to 275 (-14.60 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS194.745610,905322378 to 322 (-14.81 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS192.8215129,116378529 to 378 (-28.54 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS191.3824546,888529774 to 529 (-31.65 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS190.1025247,9057741 K to 774 (-24.56 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS189.0716431,0071,0261.2 K to 1 K (-13.78 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS187.0816430,6811,1901.4 K to 1.2 K (-12.11 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS185.741,075199,6651,3542.4 K to 1.4 K (-44.26 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS184.5914526,7662,4292.6 K to 2.4 K (-5.63 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS183.3525646,9372,5742.8 K to 2.6 K (-9.05 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS181.8617131,0992,8303 K to 2.8 K (-5.70 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...SellS181.0916830,4233,0013.2 K to 3 K (-5.30 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...BuyM5.952,06212,2693,1691.1 K to 3.2 K (+186.27 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...BuyM46.0041619,1361,107691 to 1.1 K (+60.20 %)
Mar 30 2021NVAXNOVAVAX INCHerrmann John A IIIEVP, Chief Legal Of ...BuyM27.6041611,482691275 to 691 (+151.27 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorOption ExerciseM3.9937,500149,4380
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorOption ExerciseM27.6010,000276,0000
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorOption ExerciseM46.0010,000460,0000
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorBuyM3.9937,500149,43857,50020 K to 57.5 K (+187.50 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorBuyM27.6010,000276,00020,00010 K to 20 K (+100.00 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorSellS229.412,446561,13410,00012.4 K to 10 K (-19.65 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorSellS228.423,120712,66112,44615.6 K to 12.4 K (-20.04 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorSellS227.434,4341,008,43515,56620 K to 15.6 K (-22.17 %)
Mar 25 2021NVAXNOVAVAX INCYOUNG JAMES FDirectorBuyM46.0010,000460,00020,00010 K to 20 K (+100.00 %)
Mar 23 2021NVAXNOVAVAX INCMCMANUS MICHAEL A JRDirectorSellS220.573,000661,7105,9519 K to 6 K (-33.52 %)
Mar 23 2021NVAXNOVAVAX INCMCMANUS MICHAEL A JRDirectorSellS221.401,000221,4008,95110 K to 9 K (-10.05 %)
Mar 17 2021NVAXNOVAVAX INCEVANS GARY CDirectorOption ExerciseM3.9918,00071,7300
Mar 17 2021NVAXNOVAVAX INCEVANS GARY CDirectorOption ExerciseM46.004,500207,0000
Mar 17 2021NVAXNOVAVAX INCEVANS GARY CDirectorOption ExerciseM99.802,000199,6000
Mar 17 2021NVAXNOVAVAX INCEVANS GARY CDirectorSellS212.0014,7683,130,81616,09930.9 K to 16.1 K (-47.84 %)

Page:   1 2 3 4 5 ... 8 next >

Contact us | Follow us on Twitter